ARCHIVES

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

Alan Davis to Retire From ACS; Five Execs Keep Top Positions

September 10, 1993

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

June 5, 2009

AACR Unanimously Backs Tough Antismoking Measure

May 18, 1984

Cancer Control: Incidence, Death Rates Continue To Fall, Annual Reports Says

April 23, 1999

In Brief: Capp Heads Roentgen Ray Society; Annual Lecture, Chair Honors Charles Spurr

June 22, 1990